Press release
Geographic Atrophy Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Manufacturers, Companies by DelveInsight
Geographic Atrophy Market
(Albany, USA) DelveInsight's "Geographic Atrophy Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Geographic Atrophy, historical and forecasted epidemiology as well as the Geographic Atrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Geographic Atrophy market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Geographic Atrophy market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Geographic Atrophy treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Geographic Atrophy market.
Request for a Free Sample Report @ Geographic Atrophy Market Forecast [https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Some facts of the Geographic Atrophy Market Report are:
* According to DelveInsight, Geographic Atrophy market size is expected to grow at a decent CAGR by 2034.
* Leading Geographic Atrophy companies working in the market are Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Regenerative Patch Technologies, Novartis, Roche, Ionis Pharmaceuticals, CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics), and others.
* Key Geographic Atrophy Therapies expected to launch in the market are Apellis Pharmaceuticals (Pegcetacoplan), Iveric bio (Zimura), Genentech/ Roche (RO7171009; RG6147), Ionis Pharmaceuticals/ Roche (IONIS-FB-LRx), NGMBiopharmaceuticals (NGM621), Stealth BioTherapeutics (Elamipretide), Regenerative Patch Technologies (CPCB-RPE1), CellCure Neurosciences/ Lineage Cell Therapeutics/ Roche (OpRegen), Novartis (PPY988/GT005), Regenerative Patch Technologies (CPCB-RPE1), Luxa Biotechnology (RPESC-RPE-4W) and others.
* In April 2025, Boehringer Ingelheim announced a study is open to adults aged 55 years and older with geographic atrophy that was diagnosed by imaging of the retina. The purpose of this study is to find out whether a medicine called BI 1584862 improves the eyes in people with geographic atrophy and to find the most suitable dose.
* In April 2025, Janssen Research & Development LLC conducted a phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD).
* In April 2025, Hoffmann-La Roche conducted a study is evaluation of the safety and tolerability of OpRegen - Human embryonic stem cell-derived retinal pigment epithelial (RPE) cells. The study will also include initial exploration of the ability of transplanted OpRegen cells to engraft, survive, and moderate disease progression.
* In February 2025, Astellas Pharma announced that the FDA approved expanded prescribing information for IZERVAYTM (avacincaptad pegol intravitreal solution) for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The approval removes the limitation on the duration of dosing, offering physicians and patients more flexibility in managing GA. On March 2024, Genentech announced results of A Phase IIa, Multicenter, Open-Label, Single-Arm Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.
* On April 2024, Boehringer Ingelheim announced results of a study about the Safety, Tolerability, and Pharmacokinetics of Intravitreal Single Rising Doses and Multiple Doses of BI 771716 in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (Open Label, Non-randomized).
* On February 2024, Apellis Pharmaceuticals announced results of a Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration.
* On March 2024, Janssen Research & Development announced results of a Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy Overview
Geographic Atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that leads to progressive and irreversible vision loss. Geographic Atrophy primarily affects the macula, the central part of the retina responsible for sharp, central vision. Geographic Atrophy is characterized by the gradual degeneration of retinal cells, retinal pigment epithelium (RPE), and the underlying choriocapillaris. Geographic Atrophy typically progresses over time and can significantly impact daily activities like reading, recognizing faces, and driving.
Geographic Atrophy is a leading cause of vision impairment in older adults and currently has no approved cure. Geographic Atrophy prevalence increases with age and is often detected in individuals over 60. Geographic Atrophy symptoms may include blurred vision, dark spots in the central vision, and difficulty adapting to low-light environments. Geographic Atrophy diagnosis is confirmed through advanced imaging techniques such as optical coherence tomography (OCT) and fundus autofluorescence (FAF).
Geographic Atrophy treatment options are limited, but ongoing research aims to slow its progression. Geographic Atrophy management includes regular monitoring, low-vision aids, and emerging therapies targeting complement pathway inhibition. Geographic Atrophy awareness is crucial for early detection and intervention. Geographic Atrophy research continues to explore innovative treatments that may preserve vision and enhance the quality of life for affected individuals.
Learn more about Geographic Atrophy treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ Geographic Atrophy Treatment Market [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Market
The Geographic Atrophy market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Geographic Atrophy market trends by analyzing the impact of current Geographic Atrophy therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Geographic Atrophy market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Geographic Atrophy market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Geographic Atrophy market in 7MM is expected to witness a major change in the study period 2020-2034.
Geographic Atrophy Epidemiology
The Geographic Atrophy epidemiology section provides insights into the historical and current Geographic Atrophy patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Geographic Atrophy market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Geographic Atrophy Epidemiology @ Geographic Atrophy Market Dynamics [https://www.delveinsight.com/report-store/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Drugs Uptake
This section focuses on the uptake rate of the potential Geographic Atrophy drugs recently launched in the Geographic Atrophy market or expected to be launched in 2020-2034. The analysis covers the Geographic Atrophy market uptake by drugs, patient uptake by therapies, and sales of each drug.
Geographic Atrophy Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Geographic Atrophy market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Geographic Atrophy Pipeline Development Activities
The Geographic Atrophy report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Geographic Atrophy key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Geographic Atrophy pipeline development activities @ Geographic Atrophy Companies and medication [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Therapeutics Assessment
Major key companies are working proactively in the Geographic Atrophy Therapeutics market to develop novel therapies which will drive the Geographic Atrophy treatment markets in the upcoming years are Apellis Pharmaceuticals, Iveric Bio (formerly Ophthotech Corporation), Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Regenerative Patch Technologies, Novartis, Roche, Ionis Pharmaceuticals, CellCure Neurosciences (a subsidiary of Lineage Cell Therapeutics), and others.
Learn more about the emerging Geographic Atrophy therapies & key companies @ Geographic Atrophy Clinical Trials and FDA Approvals [https://www.delveinsight.com/sample-request/geographic-atrophy-ga-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr]
Geographic Atrophy Report Key Insights
1. Geographic Atrophy Patient Population
2. Geographic Atrophy Market Size and Trends
3. Key Cross Competition in the Geographic Atrophy Market
4. Geographic Atrophy Market Dynamics (Key Drivers and Barriers)
5. Geographic Atrophy Market Opportunities
6. Geographic Atrophy Therapeutic Approaches
7. Geographic Atrophy Pipeline Analysis
8. Geographic Atrophy Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Geographic Atrophy Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Geographic Atrophy Competitive Intelligence Analysis
4. Geographic Atrophy Market Overview at a Glance
5. Geographic Atrophy Disease Background and Overview
6. Geographic Atrophy Patient Journey
7. Geographic Atrophy Epidemiology and Patient Population
8. Geographic Atrophy Treatment Algorithm, Current Treatment, and Medical Practices
9. Geographic Atrophy Unmet Needs
10. Key Endpoints of Geographic Atrophy Treatment
11. Geographic Atrophy Marketed Products
12. Geographic Atrophy Emerging Therapies
13. Geographic Atrophy Seven Major Market Analysis
14. Attribute Analysis
15. Geographic Atrophy Market Outlook (7 major markets)
16. Geographic Atrophy Access and Reimbursement Overview
17. KOL Views on the Geographic Atrophy Market
18. Geographic Atrophy Market Drivers
19. Geographic Atrophy Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=geographic-atrophy-treatment-market-2034-ema-pdma-fda-approvals-medication-nice-approvals-clinical-trials-revenue-statistics-therapies-manufacturers-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/ats-conference-coverage
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geographic Atrophy Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Manufacturers, Companies by DelveInsight here
News-ID: 4033281 • Views: …
More Releases from ABNewswire
Holiday Skin Stress? KREMOLOGIE Trademark Offers Professional Solutions for Sens …
Professional-grade skincare brand KREMOLOGIE addresses the seasonal skin challenges facing women this holiday season. With formulations rooted in clinical esthetics expertise, the brand provides barrier-strengthening solutions for reactive skin stressed by holiday demands, travel, and harsh winter conditions.
The holiday season brings joy, celebration, and unfortunately for many women, significant skin stress. Between November and January, dermatologists and estheticians report increased consultations for dehydration, sensitivity flare-ups, and accelerated aging signs. KREMOLOGIE…
Jupiter Landscaping Boosts Home Values in Boynton Beach With High End Landscape …
Jupiter Landscaping enhances Boynton Beach homes with luxury landscape designs, boosting curb appeal and property value.
Boynton Beach, FL - Landscaping experts in Boynton Beach are making a significant impact on home values with their top-tier landscape designs. Specializing in custom landscaping solutions, these professionals offer comprehensive services that enhance curb appeal, create functional outdoor spaces, and increase property value, especially for homeowners seeking Boynton Beach landscaping [https://www.jupiterlandscaping.net/boynton-beach-fl].
"We believe that landscaping…
Naples Comfort Systems Delivers Emergency AC Installation Solutions to Protect G …
Naples Comfort Systems provides fast emergency AC installation to keep Golden Gate families safe and cool during extreme heat.
Naples, FL - In response to the sweltering temperatures affecting Golden Gate and surrounding areas, Naples Comfort Systems is offering AC Installation Golden Gate FL [https://stahlmanac.com/air-conditioning/golden-gate-fl/] services on an emergency basis to help protect local families from the dangers of extreme heat. As the summer heat intensifies, the company is stepping up…
Emergency AC Repair Support Expanded in Golden Gate as Heat Intensifies
Emergency AC repair services in Golden Gate expand as rising temperatures increase demand for fast, reliable cooling solutions.
Naples, FL - As temperatures in Golden Gate and surrounding areas rise to extreme levels, homeowners and businesses are facing the critical need for reliable air conditioning services. To meet this growing demand, Naples Comfort Systems is significantly boosting its emergency AC Repair Golden Gate FL [https://stahlmanac.com/air-conditioning/golden-gate-fl/], ensuring that residents and businesses stay…
More Releases for Geographic
Geographic Information System (GIS) Software Global Market Report 2024 - Geograp …
"The Business Research Company recently released a comprehensive report on the Global Geographic Information System (GIS) Software Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The…
Cybersecurity Market Regional Analysis | Evaluating Geographic Trends
Cybersecurity Market Scope and Overview
In the digital era, where information is the new currency, cybersecurity emerges as a paramount concern for individuals, businesses, and governments alike. With the exponential growth of cyber threats, the global Cybersecurity Market has witnessed a surge in demand for innovative solutions and services to safeguard sensitive data and critical infrastructure. This report delves into a comprehensive analysis of the cybersecurity market, covering key players, market…
Geographic Information System - Comprehensive Analysis
GIS is used to power millions of decisions every day all over the world, such as examining crime patterns, pinpointing novel store locations, directing in-car navigation, and predicting and forecasting the weather, among others. The growing demand for location-based analytics among businesses to enhance operational efficiency and improve decision-making is driving the market growth. Similarly, the necessity to combine traditional data with three-dimensional data to get valuable insights from location-based…
Automobile Accessories Market: Charting New Geographic Territory
An extensive analysis of the Automobile Accessories market strategy of the leading companies in the precision of import/export consumption, supply and demand figures, cost, price, revenue and gross margins. The report starts by an introduction about the company profiling and a comprehensive review about the strategy concept and the tools that can be used to assess and analyze strategy. It also analyzes the company’s strategy in the light of Porter’s…
Geographic Atrophy - Pipeline Review, H2 2018 - ResearchByMarkets.com
"Geographic Atrophy - Pipeline Review, H2 2018", provides an overview of the Geographic Atrophy (Ophthalmology) pipeline landscape.
Geographic atrophy is an advanced form of age-related macular degeneration that can result in the progressive and irreversible loss of retina which can lead to a loss of visual function over time. Symptoms include difficulty during reading. Risk factors include smoking, thyroid hormones or antacids and in patients with coronary heart diseases and cataract…
MapsOfWorld.com partners with National Geographic Maps
MapsOfWorld.com has proudly partnered with National Geographic Maps to sell National Geographic maps and atlases in the United States. All wall maps are available at an initial discount of 15%, along with additional discounts on bulk items ordered by corporations and schools. Range of products available for sale include: paper and laminated wall maps, mural (wall paper) maps, travel maps and atlases. Wall maps are available in National Geographic’s three…
